Inflammatory skin responses induced by icatibant injection are mast cell mediated and attenuated by H 1-antihistamines

Experimental Dermatology

Volumn 21, Issue 2, 2012, Pages 154-155

  Maurer, Marcus ^a   Church, Martin K ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cetirizine; H 1 antihistamine; Icatibant mast cell; Wheal and flare

Indexed keywords

CETIRIZINE; ICATIBANT;

CONTROLLED STUDY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; MAST CELL; SKIN INFLAMMATION;

ADRENERGIC BETA-ANTAGONISTS; BRADYKININ; DRUG ERUPTIONS; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; LEUKOTRIENE C4; MAST CELLS; PIPERAZINES; PROSTAGLANDIN D2; TRYPTASES;

EID: 84855694108     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2011.01410.x     Document Type: Letter

References (9)

1. Cicardi M, Banerji A, Bracho F et al. N Engl J Med 2010: 363 (6): 532-541.
2. Maurer M, Magerl M. J Dtsch Dermatol Ges 2010: 8 (9): 663-672.
3. SPC Icatibant. Firazyr 30mg solution for injection in pre-filled syringe. 2011.
4. Cohan V L, MacGlashan D W J, Warner J A et al. Biochem Pharmacol 1991: 41: 293-300.
5. Caulfield J P, El Lati S G, Thomas G et al. Lab Invest 1990: 63: 502-510.
6. Church M K, Clough G F. Ann Allergy Asthma Immunol 1999: 83 (5): 471-475.
7. Weller K, Maurer M. J Invest Dermatol 2009: 129 (11): 2723-2726.
8. Siraganian R P. J Immunol Methods 1975: 3: 283-290.
9. Schwartz L B, Bradford T R. J Biol Chem 1986: 261: 7372-7379.